Accelerate oncology development with a purpose-built, integrated CRO delivering proven success across 2,500+ trials. Precision's comprehensive lab and clinical solutions transform complex challenges into opportunities, with 70% of our portfolio dedicated to advancing innovative cancer treatments. Our scientific expertise and responsive operations deliver faster, cost-efficient results from early development through commercialization.
Complete the form below to book a meeting with our Precision team.
Harpreet Singh, MD
Chief Medical Officer
(SizeLimitingPyList: [linkedin])
Stephen Defusco
Director of Business and Program Development
(SizeLimitingPyList: [linkedin])
Chris James
Senior Director, Business Development
(SizeLimitingPyList: [linkedin])
Panel Discussion
Enhanced Strategic FDA Collaboration: Working with CDER and CBER
.png?width=313&height=376&name=Image%2047%20(2).png)